Experimental Study on the Attenuation Function of the NLX Capsule to Lomustine

LIAO Zi-jun,CAO Fang,YAO Jun-tao,ZHAO Zheng,LIANG Qin-long,BAI Xin-kuan
DOI: https://doi.org/10.15912/j.cnki.gocm.2013.36.044
2013-01-01
Abstract:Objective To observe the prevention treatment of the NLX Capsule on injury of bone marrow, liver and kidney function induced by cyclohexyl nitrosourea(CCNU)in S180-bearing mice. Methods The S180-bearing mouse were randomLy divided into 6 eaqual goups: control group(gavaged by saline), cyclohexyl nitrosourea group(gavage by 40mg/kg of CCNU), CCNU + low-dose NLX group, CCNU + middle-dose NLX group, CCNU + high-dose NLX group(gavage by 2.5%, 5%, 10% of the NLX capsule suspension and cancellation of CCNU 40mg/kg), and Pingxiao capsule + CCNU group(gavaged by 5% Pingxiao capsule suspensions and 40mg/kg of CCNU). Peripheral blood, liver and kidney function, bone marrow granulocyte and erythrocyte count were detected, spleen and thymus index were also measured. Results In S180-bearing mice, NLX capsule with 500, 1000, 2000 mg/kg plus CCNU, could antagonize white blood cells and reticulocytes reduce induced by CCNU(P<0.01), promote bone marrow granulocyte ratio increased and red blood cell ratio declined(P<0.01), reduce liver damage(P<0.05), renal function had no significant effect(P>0.05), can be elevated tumor thymus and spleen index in S180- bearing mice(P<0.01). Conclusion NLX capsules against cytotoxic cyclohexyl nitrosourea induced bone marrow function and liver dysfunction and immune inhibition.
What problem does this paper attempt to address?